<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Safety Observer-Regulatory Intelligence</title>
<link rel="stylesheet" href="./style.css">

</head>
<body>
    <header>
        <ul>
            <li>Safety Observer</li>
            <li>Home</li>
            <li>Plans</li>
            <li>News</li>
            <li>Assistance</li>
            <li>Login</li>
            <button>Sign up for alerts</button>
        </ul>

    </header>
    
    <div>
        <h1>
            Regulatory Intelligence, staight to your mailbox
        </h1>
        <p> Stay on top of Human Pharmacovigilance requirements 
            with our monthly Regulatory Intelligence Reports.
        </p>
        <button>Sign up for alerts</button>
        <button>View Plans</button>
    </div>
   
        
    

    <fieldset>
        <ul>
            <li>Monthly reports</li>
            <li>Subscrition plans</li>
            <li>Over 70 Pharma & Biotech clients</li>
            <li>Over 3,000 users</li>
        </ul>
    </fieldset>
    <fieldset>
        <section>

            <h4>Latest report</h4>
            <h4>March 2022</h4>
            <h1>Safety Observer 187</h1>
            <p>The EMA has revised its RMP guidance for COVID-19 vaccines whith updated requirements for Summary Safety Reports.</p>
            <p>Realeased 9-Mar-2022</p>
            <p>Pages 29</p>
            <button>Buy-72€</button>
            <button>Highlights</button>
        </section>
    </fieldset>
    
    <fieldset>
        <section1>
            <h4>Past Reports</h4>
            <p>February 2022</p>
            <h5>Safety Observer 186</h5>
            <p>The new EU Clinical Trial Regulation became applicable as the CTIS went live on 31-Jan-2022.</p>
            <button>Buy-72€</button>
            <button>Highlights</button>
        </section1>
        
        <section2>
            <p>January 2022</p>
            <h5>Safety Observer 185</h5>
            <p>Both the US FDA and the MHRA have published new guidance to promote the use of RWD in clinical trials.</p>
            <button>Buy-72€</button>
            <button>Highlights</button>
        </section2>
        <section3>
            <p>December 2021</p>
            <h5>Safety Observer 184</h5>
            <p> The  FDA has  published a new  draft guidance that provides consoderations for the use of registries.</p>
            <button>Buy-72€</button>
            <button>Highlights</button>
        </section3>
    </fieldset>
    <section4>
        <h2>3-Month Plan</h2>
        <p>This Plan includes three  consecutive reports starting whith the next release. 
            The perfect solution to test the value of our service.
        </p>
        <h5>Starts at 180€</h5>
        <ul>
        
            <li>3 Regulatory Intelligence Reports</li>
            <li>Volume pricing available</li>
            <li>16% OFF</li>
        </ul>
        <button>Buy 3-Month Plan</button>
        <button>More Info</button>
    </section4>
    <section5>
        <h2>1-Year Plan</h2>
        <p>This Plan includes three  consecutive reports starting whith the next release. 
            The perfect solution to test the value of our service.
        </p>
        <h5>Starts at 600€</h5>
        <ul>
        
            <li>11 Regulatory Intelligence Reports</li>
            <li>Volume pricing available</li>
            <li>24% OFF</li>
        </ul>
        <button>Buy 1-Year Plan</button>
        <button>More Info</button>
    </section5>
    <section6>
        <h2>Supporting the global Pharmacovigilance community since 2005</h2>
        <p>We are proud to serve pharmacovigilance professionals in more than 100 organisations across the world, including major pharma corporations, small biotech, service providers, and public hospitals.
        </p>
        <button>About us</button>
    </section6>

    <footer>Safety Observer, 2005-2021
       <a href="https://safetyobserver.com/legal/">Legal</a>
       <a href="https://www.linkedin.com/company/safety-observer/">Linkedin</a>
       <a href="https://twitter.com/safetyobserver">twitter</a>
    </footer>


</body>
</html>